Entropy Technologies LP Raises Position in Teleflex Incorporated (NYSE:TFX)

Entropy Technologies LP raised its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 20.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,789 shares of the medical technology company’s stock after buying an additional 1,173 shares during the period. Entropy Technologies LP’s holdings in Teleflex were worth $1,208,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in TFX. Cromwell Holdings LLC lifted its stake in shares of Teleflex by 59.0% in the 3rd quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company’s stock valued at $33,000 after acquiring an additional 49 shares during the last quarter. Apollon Wealth Management LLC lifted its position in Teleflex by 3.7% in the third quarter. Apollon Wealth Management LLC now owns 1,524 shares of the medical technology company’s stock valued at $377,000 after purchasing an additional 55 shares during the last quarter. SRS Capital Advisors Inc. boosted its stake in shares of Teleflex by 0.3% during the third quarter. SRS Capital Advisors Inc. now owns 19,587 shares of the medical technology company’s stock valued at $4,844,000 after purchasing an additional 60 shares during the period. Janney Montgomery Scott LLC grew its holdings in shares of Teleflex by 0.4% in the third quarter. Janney Montgomery Scott LLC now owns 15,332 shares of the medical technology company’s stock worth $3,792,000 after purchasing an additional 65 shares during the last quarter. Finally, Tokio Marine Asset Management Co. Ltd. increased its stake in shares of Teleflex by 4.5% in the third quarter. Tokio Marine Asset Management Co. Ltd. now owns 1,517 shares of the medical technology company’s stock worth $375,000 after buying an additional 66 shares during the period. 95.62% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

TFX has been the subject of several analyst reports. StockNews.com raised shares of Teleflex from a “hold” rating to a “buy” rating in a research report on Thursday, November 28th. Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a research note on Monday, December 16th. Royal Bank of Canada reduced their price target on Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a report on Friday, November 1st. Truist Financial dropped their price objective on Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a report on Wednesday, December 18th. Finally, Mizuho reduced their target price on Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a research note on Friday, November 1st. Three investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $252.50.

Teleflex Stock Performance

Teleflex stock opened at $171.67 on Tuesday. Teleflex Incorporated has a fifty-two week low of $170.21 and a fifty-two week high of $256.85. The stock has a market cap of $7.97 billion, a price-to-earnings ratio of 34.13, a PEG ratio of 1.72 and a beta of 1.16. The stock’s 50 day simple moving average is $180.04 and its two-hundred day simple moving average is $211.07. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.